2,650 research outputs found
Some doubts on the validity of the foreground Galactic contribution subtraction from microwave anisotropies
The Galactic foreground contamination in CMBR anisotropies, especially from
the dust component, is not easily separable from the cosmological or
extragalactic component. In this paper, some doubts will be raised concerning
the validity of the methods used to date to remove Galactic dust emission in
order to show that none of them achieves its goal.
First, I review the recent bibliography on the topic and discuss critically
the methods of foreground subtraction: the cross-correlation with templates,
analysis assuming the spectral shape of the Galactic components, the "maximum
entropy method", "internal linear combination", and "wavelet-based high
resolution fitting of internal templates". Second, I analyse the galactic
latitude dependence from WMAP data. The frequency dependence is discussed with
the data in the available literature. The result is that all methods of
subtracting the Galactic contamination are inaccurate. The galactic latitude
dependence analysis or the frequency dependence of the anisotropies in the
range 50-250 GHz put a constraint on the maximum Galactic contribution in the
power spectrum to be less than a ~10% (68% C. L.) for a ~1 degree scale, and
possibly higher for larger scales.
The origin of most of the signal in the CMBR anisotropies is not Galactic. In
any case, the subtraction of the Galaxy is not accurate enough to allow a
"precision Cosmology"; other sources of contamination (extragalactic, solar
system) are also present.Comment: 24 pages, 1 figure, accepted to be published in J. Astrophys. Ast
Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease
Deregulated protein and Ca2+ homeostasis underlie synaptic dysfunction and neurodegeneration in Huntington disease
(HD); however, the factors that disrupt homeostasis are not fully understood. Here, we determined that expression of
downstream regulatory element antagonist modulator (DREAM), a multifunctional Ca2+-binding protein, is reduced in
murine in vivo and in vitro HD models and in HD patients. DREAM downregulation was observed early after birth and was
associated with endogenous neuroprotection. In the R6/2 mouse HD model, induced DREAM haplodeficiency or blockade
of DREAM activity by chronic administration of the drug repaglinide delayed onset of motor dysfunction, reduced striatal
atrophy, and prolonged life span. DREAM-related neuroprotection was linked to an interaction between DREAM and the
unfolded protein response (UPR) sensor activating transcription factor 6 (ATF6). Repaglinide blocked this interaction and
enhanced ATF6 processing and nuclear accumulation of transcriptionally active ATF6, improving prosurvival UPR function
in striatal neurons. Together, our results identify a role for DREAM silencing in the activation of ATF6 signaling, which
promotes early neuroprotection in HDThis work was funded by the Instituto de Salud Carlos III/CIBERNED (to J.R. Naranjo, B. Mellström, and A. Rábano), FISS-RIC RD12/0042/0019 (to C. Valenzuela), Madrid regional government/Neurodegmodels (to J.R. Naranjo), MINECO grants SAF2010-21784 and SAF2014-53412-R (to J.R. Naranjo), SAF2012-32209 (to M. Gutierrez-Rodriguez), SAF2010-14916 and SAF2013-45800-R (to C. Valenzuela), and a grant from the Swedish Research Council (J.Y. Li
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response-adapted therapy with rituximab, bendamustine, mitoxantrone, and dexamethasone (RBMD) in follicular lymphoma patients who relapsed after or were refractory to first-line immunochemotherapy. Sixty patients received three treatment cycles, and depending on their response received an additional one (complete/unconfirmed complete response) or three (partial response) cycles. Patients who responded to induction received rituximab maintenance therapy for 2 years. Results Thirty-three (55%) and 42 (70%) patients achieved complete/unconfirmed complete response after three cycles and on completing induction therapy (4-6 cycles), respectively (final overall response rate, 88.3%). Median progression-free survival was 56.4 months (median follow-up, 28.3 months; 95% CI, 15.6-51.2). Overall survival was not reached. Progression-free survival did not differ between patients who received four vs six cycles (P = .6665), nor between patients who did/did not receive rituximab maintenance after first-line therapy (P = .5790). Median progression-free survival in the 10 refractory patients was 25.5 months (95% CI, 0.6-N/A) and was longer in patients who had shown progression of disease after 24 months of first-line therapy (median, 56.4 months; 95% CI, 19.8-56.4) than in those who showed early progression (median, 42.31 months; 95% CI, 24.41-NA) (P = .4258). Thirty-six (60%) patients had grade 3/4 neutropenia. Grade 3/4 febrile neutropenia and infection were recorded during induction (4/60 [6.7%] and 5/60 [8.3%] patients, respectively) and maintenance (2/43 [4.5%] and 4/43 [9.1%] patients, respectively). Conclusions This response-adapted treatment with RBMD followed by rituximab maintenance is an effective and well-tolerated salvage treatment for relapsed/refractory follicular lymphoma following first-line immunochemotherapy
Observation of two new baryon resonances
Two structures are observed close to the kinematic threshold in the mass spectrum in a sample of proton-proton collision data, corresponding
to an integrated luminosity of 3.0 fb recorded by the LHCb experiment.
In the quark model, two baryonic resonances with quark content are
expected in this mass region: the spin-parity and
states, denoted and .
Interpreting the structures as these resonances, we measure the mass
differences and the width of the heavier state to be
MeV,
MeV,
MeV, where the first and second
uncertainties are statistical and systematic, respectively. The width of the
lighter state is consistent with zero, and we place an upper limit of
MeV at 95% confidence level. Relative
production rates of these states are also reported.Comment: 17 pages, 2 figure
Direct measurement of the mass difference between top and antitop quarks
We present a direct measurement of the mass difference between top and
antitop quarks (dm) in lepton+jets top-antitop final states using the "matrix
element" method. The purity of the lepton+jets sample is enhanced for
top-antitop events by identifying at least one of the jet as originating from a
b quark. The analyzed data correspond to 3.6 fb-1 of proton-antiproton
collisions at 1.96 TeV acquired by D0 in Run II of the Fermilab Tevatron
Collider. The combination of the e+jets and mu+jets channels yields dm = 0.8
+/- 1.8 (stat) +/- 0.5 (syst) GeV, which is in agreement with the standard
model expectation of no mass difference.Comment: submitted to Phys. Rev.
Precise measurement of the top quark mass in the dilepton channel at D0
We measure the top quark mass (mt) in ppbar collisions at a center of mass
energy of 1.96 TeV using dilepton ttbar->W+bW-bbar->l+nubl-nubarbbar events,
where l denotes an electron, a muon, or a tau that decays leptonically. The
data correspond to an integrated luminosity of 5.4 fb-1 collected with the D0
detector at the Fermilab Tevatron Collider. We obtain mt = 174.0 +- 1.8(stat)
+- 2.4(syst) GeV, which is in agreement with the current world average mt =
173.3 +- 1.1 GeV. This is currently the most precise measurement of mt in the
dilepton channel.Comment: 7 pages, 4 figure
Search for the standard model and a fermiophobic Higgs boson in diphoton final states
We present a search for the standard model Higgs boson and a fermiophobic
Higgs boson in the diphoton final states based on 8.2 fb-1 of ppbar collisions
collected with the D0 detector at the Fermilab Tevatron Collider. No excess of
data above background predictions is observed and upper limits at the 95% C.L.
on the cross section multiplied by the branching fraction are set which are the
most restrictive to date. A fermiophobic Higgs boson with a mass below 112.9
GeV is excluded at the 95% C.L.Comment: 12 pages, 21 figures, submitted to PR
Search for first generation leptoquark pair production in the electron + missing energy + jets final state
We present a search for the pair production of first generation scalar
leptoquarks (LQ) in data corresponding to an integrated luminosity of 5.4
fb collected with the D0 detector at the Fermilab Tevatron Collider in
ppbar collisions at TeV. In the channel , where q, q' are u or d quarks, no significant excess
of data over background is observed, and we set a 95% C.L. lower limit of 326
GeV on the leptoquark mass, assuming equal probabilities of leptoquark decays
to eq and .Comment: 7 pages, 6 figures, submitted to PRD-R
Journal Staff
We present the first measurements of the differential cross section d sigma/dp(T)(gamma) for the production of an isolated photon in association with at least two b-quark jets. The measurements consider photons with rapidities vertical bar y(gamma)vertical bar < 1.0 and transverse momenta 30 < p(T)(gamma) < 200 GeV. The b-quark jets are required to have p(T)(jet) > 15 GeVand vertical bar y(jet)vertical bar < 1.5. The ratio of differential production cross sections for gamma + 2 b-jets to gamma + b-jet as a function of p(T)(gamma) is also presented. The results are based on the proton-antiproton collision data at root s = 1.96 TeV collected with the D0 detector at the Fermilab Tevatron Collider. The measured cross sections and their ratios are compared to the next- to- leading order perturbative QCD calculations as well as predictions based on the k(T)- factorization approach and those from the sherpa and pythia Monte Carlo event generators
- …